What's breaking now, across thousands of outlets.
Sunharbo’s U.S. approval is the first for a “Factor XIa” inhibitor, an anticipated class of medicines seen as a possible step forward in stroke prevention.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
(MedPage Today) -- In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of metabolic dysfunction-associated steatohepatitis…
Injecting an ordinary flu vaccine straight into skin cancer tumors may help rally the immune system against the cancer, a small early trial suggests.
Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
Intensive blood pressure-lowering treatment to reduce systolic pressure below 120 mm Hg in adults with type 2 diabetes, who are at increased risk of cardiovascular events, did not significantly reduce…
Doctors told Danny Ellis it was a "miracle" he was alive after his first heart surgery failed.
(MedPage Today) -- The enthusiasm for smartwatch detection of left ventricular systolic dysfunction (LVSD) was tempered by a Korean study indicating difficulties with the technology in its current…
